Ymmunobio

About:

Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments.

Website: https://www.ymmunobio.com

Description:

Ymmunobio is a preclinical-stage oncology biotech startup committed to creating advanced cancer patient treatments. It makes extensive progress in developing antibodies that have an influence on the immune system by reinstating its immune response to cancers or directly inhibiting cancer cell proliferation.

Total Funding Amount:

$1.4M

Headquarters Location:

Basel, Basel-Stadt, Switzerland

Founded Date:

2021-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-11-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai